Stoke Therapeutics Inc. (STOK)
NASDAQ: STOK
· Real-Time Price · USD
24.14
1.19 (5.19%)
At close: Sep 26, 2025, 3:59 PM
24.65
2.11%
After-hours: Sep 26, 2025, 07:56 PM EDT
Stoke Therapeutics Revenue
Stoke Therapeutics reported an annual revenue of $36.55M, reflecting a 316.34% growth. For the quarter ending June 30, 2025, Stoke Therapeutics generated $13.82M in revenue.
Revenue (ttm)
36.55M
Revenue Growth
316.34%
Price / Sales Ratio
16.3
Revenue / Employee
285.59K
Employees
128
Market Cap
1.32B
Revenue Chart
History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 36.55M | +316.34% |
| Dec 31, 2023 | 8.78M | -29.22% |
| Dec 31, 2022 | 12.4M | +Infinity% |
| Dec 31, 2021 | 0 | n/a |
| Dec 31, 2020 | 0 | n/a |
| Dec 31, 2019 | 0 | n/a |
| Dec 31, 2018 | 0 | n/a |
| Dec 31, 2017 | 0 | n/a |